155 related articles for article (PubMed ID: 36628153)
1. Drug-Coated versus Uncoated Balloon for Side Branch Protection in Coronary Bifurcation Lesions Treated with Provisional Stenting Using Drug-Eluting Stents: A Meta-analysis.
Jiang ZM; Liu L
Int J Clin Pract; 2022; 2022():5892589. PubMed ID: 36628153
[TBL] [Abstract][Full Text] [Related]
2. A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in bifurcation lesions treated with a single-stenting technique: six-month angiographic and 12-month clinical results of the drug-eluting balloon in bifurcations trial.
Stella PR; Belkacemi A; Dubois C; Nathoe H; Dens J; Naber C; Adriaenssens T; van Belle E; Doevendans P; Agostoni P
Catheter Cardiovasc Interv; 2012 Dec; 80(7):1138-46. PubMed ID: 22422607
[TBL] [Abstract][Full Text] [Related]
3. Choice of stenting strategy in true coronary artery bifurcation lesions.
Lin QF; Luo YK; Lin CG; Peng YF; Zhen XC; Chen LL
Coron Artery Dis; 2010 Sep; 21(6):345-51. PubMed ID: 20613498
[TBL] [Abstract][Full Text] [Related]
4. Comparison of angiographic change in side-branch ostium after drug-coated balloon vs. drug-eluting stent vs. medication for the treatment of de novo coronary bifurcation lesions.
Her AY; Kim B; Kim S; Kim YH; Scheller B; Shin ES
Eur J Med Res; 2024 May; 29(1):280. PubMed ID: 38735968
[TBL] [Abstract][Full Text] [Related]
5. Rationale and design for comparison of non-compliant balloon with drug-coating balloon angioplasty for side branch after provisional stenting for patients with true coronary bifurcation lesions: a prospective, multicentre and randomised DCB-BIF trial.
Gao XF; Ge Z; Kan J; Kong XQ; Wang Y; Qiu CG; Tresukosol D; He YQ; Wu Q; Li JF; Yuan HT; Shen C; Chen X; Munawar M; Hanif B; Santoso T; Shin ES; Sheiban I; Ye F; Zhang JJ; Chen SL;
BMJ Open; 2022 Mar; 12(3):e052788. PubMed ID: 35277400
[TBL] [Abstract][Full Text] [Related]
6. A Non-inferiority, Randomized Clinical Trial Comparing Paclitaxel-Coated Balloon Versus New-Generation Drug-Eluting Stents on Angiographic Outcomes for Coronary De Novo Lesions.
Yu X; Wang X; Ji F; Zhang W; Yang C; Xu F; Wang F
Cardiovasc Drugs Ther; 2022 Aug; 36(4):655-664. PubMed ID: 33713211
[TBL] [Abstract][Full Text] [Related]
7. A novel hybrid strategy of drug coated balloon and stent for coronary bifurcation lesions.
Yang H; Song Y; Cao J; Chen J; Zhang F; Huang Z; Qian J; Ge J
Scand Cardiovasc J; 2023 Dec; 57(1):2161620. PubMed ID: 36573618
[No Abstract] [Full Text] [Related]
8. Prospective randomized comparison of sirolimus- or everolimus-eluting stent to treat bifurcated lesions by provisional approach.
Burzotta F; Trani C; Todaro D; Mariani L; Talarico GP; Tommasino A; Giammarinaro M; Niccoli G; Porto I; Leone AM; Mongiardo R; Mazzari MA; Schiavoni G; Crea F
JACC Cardiovasc Interv; 2011 Mar; 4(3):327-35. PubMed ID: 21435612
[TBL] [Abstract][Full Text] [Related]
9. Long-term risk of clinical events from stenting side branches of coronary bifurcation lesions with drug-eluting and bare-metal stents: an observational meta-analysis.
Zamani P; Kinlay S
Catheter Cardiovasc Interv; 2011 Feb; 77(2):202-12. PubMed ID: 20824754
[TBL] [Abstract][Full Text] [Related]
10. Randomized Comparison of FFR-Guided and Angiography-Guided Provisional Stenting of True Coronary Bifurcation Lesions: The DKCRUSH-VI Trial (Double Kissing Crush Versus Provisional Stenting Technique for Treatment of Coronary Bifurcation Lesions VI).
Chen SL; Ye F; Zhang JJ; Xu T; Tian NL; Liu ZZ; Lin S; Shan SJ; Ge Z; You W; Liu YQ; Qian XS; Li F; Yang S; Kwan TW; Xu B; Stone GW
JACC Cardiovasc Interv; 2015 Apr; 8(4):536-46. PubMed ID: 25819187
[TBL] [Abstract][Full Text] [Related]
11. Drug-Coated Balloons versus Everolimus-Eluting Stents in Patients with In-Stent Restenosis: A Pair-Wise Meta-Analysis of Randomized Trials.
Peng N; Liu W; Li Z; Wei J; Chen X; Wang W; Lin H
Cardiovasc Ther; 2020; 2020():1042329. PubMed ID: 32411298
[TBL] [Abstract][Full Text] [Related]
12. A randomized trial of a dedicated bifurcation stent versus provisional stenting in the treatment of coronary bifurcation lesions.
Généreux P; Kumsars I; Lesiak M; Kini A; Fontos G; Slagboom T; Ungi I; Metzger DC; Wykrzykowska JJ; Stella PR; Bartorelli AL; Fearon WF; Lefèvre T; Feldman RL; LaSalle L; Francese DP; Onuma Y; Grundeken MJ; Garcia-Garcia HM; Laak LL; Cutlip DE; Kaplan AV; Serruys PW; Leon MB
J Am Coll Cardiol; 2015 Feb; 65(6):533-43. PubMed ID: 25677311
[TBL] [Abstract][Full Text] [Related]
13. Improved Outcomes of Combined Main Branch Stenting and Side Branch Drug-Coated Balloon versus Two-Stent Strategy in Patients with Left Main Bifurcation Lesions.
Liu H; Tao H; Han X; Lu Y; Xue X; Feng R; Lv F; Liu Y; Jin H; Li L; Gu H
J Interv Cardiol; 2022; 2022():8250057. PubMed ID: 35095348
[TBL] [Abstract][Full Text] [Related]
14. Randomized study of the crush technique versus provisional side-branch stenting in true coronary bifurcations: the CACTUS (Coronary Bifurcations: Application of the Crushing Technique Using Sirolimus-Eluting Stents) Study.
Colombo A; Bramucci E; Saccà S; Violini R; Lettieri C; Zanini R; Sheiban I; Paloscia L; Grube E; Schofer J; Bolognese L; Orlandi M; Niccoli G; Latib A; Airoldi F
Circulation; 2009 Jan; 119(1):71-8. PubMed ID: 19103990
[TBL] [Abstract][Full Text] [Related]
15. Second-generation drug-eluting stents versus drug-coated balloons for the treatment of coronary in-stent restenosis: A systematic review and meta-analysis.
Kokkinidis DG; Prouse AF; Avner SJ; Lee JM; Waldo SW; Armstrong EJ
Catheter Cardiovasc Interv; 2018 Aug; 92(2):285-299. PubMed ID: 29024274
[TBL] [Abstract][Full Text] [Related]
16. Randomized Comparisons Between Different Stenting Approaches for Bifurcation Coronary Lesions With or Without Side Branch Stenosis.
Kim YH; Lee JH; Roh JH; Ahn JM; Yoon SH; Park DW; Lee JY; Yun SC; Kang SJ; Lee SW; Lee CW; Seung KB; Shin WY; Lee NH; Lee BK; Lee SG; Nam CW; Yoon J; Yang JY; Hyon MS; Lee K; Jang JS; Kim HS; Park SW; Park SJ
JACC Cardiovasc Interv; 2015 Apr; 8(4):550-60. PubMed ID: 25907082
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of drug-eluting balloons in percutaneous treatment of bifurcation lesions: the DEBIUT (drug-eluting balloon in bifurcation Utrecht) registry.
Fanggiday JC; Stella PR; Guyomi SH; Doevendans PA
Catheter Cardiovasc Interv; 2008 Apr; 71(5):629-35. PubMed ID: 18360855
[TBL] [Abstract][Full Text] [Related]
18. Interventional therapy of bifurcation lesions: a TIMI flow-guided concept to treat side branches in bifurcation lesions--a prospective randomized clinical study (Thueringer bifurcation study, THUEBIS study as pilot trial).
Korn HV; Yu J; Ohlow MA; Huegl B; Schulte W; Wagner A; Wassmer G; Gruene S; Petek O; Lauer B
Circ Cardiovasc Interv; 2009 Dec; 2(6):535-42. PubMed ID: 20031771
[TBL] [Abstract][Full Text] [Related]
19. Randomised comparison of provisional side branch stenting versus a two-stent strategy for treatment of true coronary bifurcation lesions involving a large side branch: the Nordic-Baltic Bifurcation Study IV.
Kumsars I; Holm NR; Niemelä M; Erglis A; Kervinen K; Christiansen EH; Maeng M; Dombrovskis A; Abraitis V; Kibarskis A; Trovik T; Latkovskis G; Sondore D; Narbute I; Terkelsen CJ; Eskola M; Romppanen H; Laine M; Jensen LO; Pietila M; Gunnes P; Hebsgaard L; Frobert O; Calais F; Hartikainen J; Aarøe J; Ravkilde J; Engstrøm T; Steigen TK; Thuesen L; Lassen JF;
Open Heart; 2020; 7(1):e000947. PubMed ID: 32076558
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy of drug coated balloon versus conventional balloon in the treatment of coronary de novo bifurcation lesions: a meta-analysis].
Xie ER; Liu C; Ni YJ; Gao DF; Deng J
Zhonghua Xin Xue Guan Bing Za Zhi; 2021 Dec; 49(12):1227-1234. PubMed ID: 34905901
[No Abstract] [Full Text] [Related]
[Next] [New Search]
